Approval · Notice of Compliance 3100 · 1998
NORTRIPTYLINE: Notice of Compliance 3100
Issued February 19, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3100
- Date
- February 19, 1998
- Company
- Pharmel Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antidepressant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NORTRIPTYLINE | 02237376 | Cancelled Post Market |
| NORTRIPTYLINE | 02237377 | Cancelled Post Market |
Medicinal ingredients
- NORTRIPTYLINE HCL 10 MG per CAP
- NORTRIPTYLINE HCL 25 MG per CAP